Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 19, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

Sentinel node mapping for breast cancer: current situation.

Sergi Vidal-Sicart1, Renato Valdés Olmos

  • 1Nuclear Medicine Department, Hospital Clínic Barcelona, 08036 Barcelona, Spain.

Journal of Oncology
|August 29, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iodine seed-marking protocol for response-guided axillary de-escalation after neoadjuvant therapy in node-positive breast cancer.

Translational cancer research·2026
Same author

Nuclear medicine in the operating room: present and future.

The British journal of radiology·2026
Same author

SUMMARY: Selective Sentinel Lymph Node Biopsy (SSLNB) in breast cancer for residents.

Revista espanola de medicina nuclear e imagen molecular·2025
Same author

Integration of the nursing care assistant profile in I-125 seed procedures for breast cancer: Clinical and professional impact.

Revista espanola de medicina nuclear e imagen molecular·2025
Same author

Sentinel node detection and imaging concordance in Early-Stage ovarian cancer: A MELISA trial analysis of tracer, timing, and intraoperative gamma camera.

European journal of nuclear medicine and molecular imaging·2025
Same author

Sentinel lymph node biopsy versus pelvic lymphadenectomy for early-stage cervical cancer: a retrospective institutional review.

Archives of gynecology and obstetrics·2025

Sentinel lymph node biopsy is a minimally invasive standard for early-stage breast cancer staging. This method accurately assesses nodal involvement, reducing complications compared to traditional dissection.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Breast Cancer Research

Background:

  • Axillary node status is a critical prognostic indicator in early-stage breast cancer.
  • Traditional staging involves extensive axillary lymph node dissection, carrying significant morbidity.
  • Metastatic axillary involvement occurs in 10%-30% of patients with T1 tumors.

Purpose of the Study:

  • To review the indications, contraindications, and methodological aspects of sentinel lymph node biopsy (SLNB).
  • To highlight SLNB as the current standard of care for stages I and II breast cancer.
  • To discuss advancements improving SLNB accuracy and reducing false negatives.

Main Methods:

  • Review of existing literature on sentinel lymph node biopsy.
  • Discussion of the principles of lymphatic mapping and metastatic progression.

More Related Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Related Experiment Videos

Last Updated: May 19, 2026

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

  • Analysis of comparative data between SLNB and axillary lymph node dissection.

    • Main Results:

    • SLNB accurately identifies nodal involvement with a false-negative rate below 5%.
    • SLNB demonstrates significantly reduced complications compared to axillary lymph node dissection.
    • SLNB achieves comparable positive node rates and similar 5-year nodal relapse rates to lymphadenectomy.

    Conclusions:

    • Sentinel lymph node biopsy is the established standard for staging early-stage breast cancer (Stages I and II).
    • This technique offers comparable oncologic outcomes with substantially lower patient morbidity.
    • Ongoing technological and histological advancements promise further improvements in SLNB accuracy and reliability.